Bristol-Myers
Squibb Company (NYSE: BMY) will take part in the Credit Suisse
Annual Health Care Conference on Tuesday, November 8, 2016 in
Scottsdale, Arizona. Fouad Namouni, senior vice president, Head Oncology
Development, will answer questions about the company at 8 a.m. MT (10
a.m. ET).
Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
###
Bristol-Myers Squibb CompanyMedia:Ken Dominski, 609-252-5251 ken.dominski@bms.com orInvestors:Tim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com